Abbott Laboratories beat EPS estimates 100% of the time across 18 reported quarters (18 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $1.28 | — | — | Miss |
| Q1 FY2026 | $1.14 | $1.15 | +0.9% | Beat |
| Q1 FY2026 | $1.15 | — | — | Miss |
| 2026-01-22 | $1.50 | $1.50 | +0.0% | Beat |
| Q3 FY2025 | $1.30 | $1.30 | +0.0% | Beat |
| Q2 FY2025 | $1.26 | $1.26 | +0.0% | Beat |
| Q1 FY2025 | $1.07 | $1.09 | +1.9% | Beat |
| 2025-01-22 | $1.34 | $1.34 | +0.0% | Beat |
| Q3 FY2024 | $1.20 | $1.21 | +0.8% | Beat |
| Q2 FY2024 | $1.10 | $1.14 | +3.6% | Beat |
| Q1 FY2024 | $0.95 | $0.98 | +2.6% | Beat |
| 2024-01-24 | $1.19 | $1.19 | +0.0% | Beat |
Back to ABT overview · ABT holders · ABT KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.